These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Increased protocollagen proline hydroxylase activity in sclerodermatous skin. Keiser HR; Stein HD; Sjoerdsma A Arch Dermatol; 1971 Jul; 104(1):57-60. PubMed ID: 5120163 [No Abstract] [Full Text] [Related]
23. Evaluation of heart rhythm variability and arrhythmia in children with systemic and localized scleroderma. Wozniak J; Dabrowski R; Luczak D; Kwiatkowska M; Musiej-Nowakowska E; Kowalik I; Szwed H J Rheumatol; 2009 Jan; 36(1):191-6. PubMed ID: 19040309 [TBL] [Abstract][Full Text] [Related]
24. [Juvenile scleroderma]. Girouard M; Paré C; Camerlain M Union Med Can; 1982 Jun; 111(6):546-51. PubMed ID: 7112751 [No Abstract] [Full Text] [Related]
25. [Systemic sclerosis--clinical course and treatment possibilities]. Szymańska E; Maj M; Rudnicka L Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791 [TBL] [Abstract][Full Text] [Related]
26. Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre. Blaszczyk M; Królicki L; Krasu M; Glinska O; Jablonska S J Rheumatol; 2003 Sep; 30(9):1997-2004. PubMed ID: 12966605 [TBL] [Abstract][Full Text] [Related]
27. [Interrelations between systemic and focal scleroderma in children]. Uvarova NN; Vlasova TM Pediatriia; 1983 Nov; (11):46-8. PubMed ID: 6669434 [No Abstract] [Full Text] [Related]
28. [The circulatory system in children with cutaneous forms of scleroderma. The results of routine as well as 24-hour ECG and physical performance test]. Rokicki W; Rubisz-Brzezińska J; Dukalska M; Rzepecka I; Gasior Z; Gołba E; Nowak Z Pediatr Pol; 1995 Jun; 70(6):479-85. PubMed ID: 8692605 [TBL] [Abstract][Full Text] [Related]
29. [Scleroatrophic lichen and its relation to scleroderma]. Kalamkarian AA; Fedorova EG Vestn Dermatol Venerol; 1982; (12):4-7. PubMed ID: 7158014 [No Abstract] [Full Text] [Related]
30. Differential diagnosis of scleroderma and pseudoscleroderma. Fabri M; Hunzelmann N J Dtsch Dermatol Ges; 2007 Nov; 5(11):977-84. PubMed ID: 17976138 [TBL] [Abstract][Full Text] [Related]
32. [On signs of instability in neurological examination of children]. Salzarulo P; Bergès J Arch Psicol Neurol Psichiatr; 1969; 30(1):37-47. PubMed ID: 5368973 [No Abstract] [Full Text] [Related]
33. [The diagnostic importance of research on the lysyl oxidase activity in children with circumscribed scleroderma]. Kudrin VI; Lashmanova AP; Akimov VG; Grebeniuk VN Vestn Dermatol Venerol; 1990; (5):14-6. PubMed ID: 1976287 [TBL] [Abstract][Full Text] [Related]
34. Prognosis and management of scleroderma and scleroderma-like disorders in children. Black CM Clin Exp Rheumatol; 1994; 12 Suppl 10():S75-81. PubMed ID: 7955633 [TBL] [Abstract][Full Text] [Related]
35. [Scleroderma. Which tests should be performed?]. Crickx B; Lazareth I Ann Dermatol Venereol; 1990; 117(1):83-6. PubMed ID: 2181910 [No Abstract] [Full Text] [Related]
36. [Characteristics of circumscribed scleroderma in children and its relation to systemic scleroderma]. Vlasova TM Pediatriia; 1988; (3):53-6. PubMed ID: 3380619 [No Abstract] [Full Text] [Related]
39. [Changes in the nervous system in children with malabsorption syndrome]. Krasil'shchikova TM Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(10):1496-1502. PubMed ID: 7435032 [TBL] [Abstract][Full Text] [Related]